Φορτώνει......
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
Checkpoint inhibitors have demonstrated efficacy in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). However, the majority of patients do not benefit from these agents. To improve the efficacy of checkpoint inhibitors, intratumoral (i.t.) injection with innate imm...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JCI Insight |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society for Clinical Investigation
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5621908/ https://ncbi.nlm.nih.gov/pubmed/28931759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.93397 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|